These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 1902334)
1. Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes. Ramsdell HS; Parkinson A; Eddy AC; Eaton DL Toxicol Appl Pharmacol; 1991 May; 108(3):436-47. PubMed ID: 1902334 [TBL] [Abstract][Full Text] [Related]
2. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428 [TBL] [Abstract][Full Text] [Related]
3. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Gallagher EP; Kunze KL; Stapleton PL; Eaton DL Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785 [TBL] [Abstract][Full Text] [Related]
4. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes. Daniels JM; Massey TE Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185 [TBL] [Abstract][Full Text] [Related]
5. Biotransformation of aflatoxin B1 in rabbit lung and liver microsomes. Daniels JM; Liu L; Stewart RK; Massey TE Carcinogenesis; 1990 May; 11(5):823-7. PubMed ID: 2110514 [TBL] [Abstract][Full Text] [Related]
6. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Shimada T; Guengerich FP Proc Natl Acad Sci U S A; 1989 Jan; 86(2):462-5. PubMed ID: 2492107 [TBL] [Abstract][Full Text] [Related]
7. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes. Takahashi N; Harttig U; Williams DE; Bailey GS Carcinogenesis; 1996 Jan; 17(1):79-87. PubMed ID: 8565141 [TBL] [Abstract][Full Text] [Related]
8. Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes. Ueng YF; Shimada T; Yamazaki H; Guengerich FP Chem Res Toxicol; 1995 Mar; 8(2):218-25. PubMed ID: 7766804 [TBL] [Abstract][Full Text] [Related]
9. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat. Stresser DM; Bailey GS; Williams DE Drug Metab Dispos; 1994; 22(3):383-91. PubMed ID: 8070314 [TBL] [Abstract][Full Text] [Related]
10. Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes. Yamazaki H; Mimura M; Oda Y; Inui Y; Shiraga T; Iwasaki K; Guengerich FP; Shimada T Carcinogenesis; 1993 Jul; 14(7):1271-8. PubMed ID: 8330339 [TBL] [Abstract][Full Text] [Related]
12. Aflatoxin B1 hydroxylation by the pregnenolone-16 alpha-carbonitrile-inducible form of rat liver microsomal cytochrome P-450. Halvorson MR; Safe SH; Parkinson A; Phillips TD Carcinogenesis; 1988 Nov; 9(11):2103-8. PubMed ID: 3141079 [TBL] [Abstract][Full Text] [Related]
13. 2(3)-tert-butyl-4-hydroxyanisole inhibits oxidative metabolism of aflatoxin B1 in isolated rat hepatocytes. Ch'ih JJ; Biedrzycka DW; Lin T; Khoo MO; Devlin TM Proc Soc Exp Biol Med; 1989 Oct; 192(1):35-42. PubMed ID: 2508094 [TBL] [Abstract][Full Text] [Related]
14. In vitro prostaglandin H synthase- and monooxygenase-mediated binding of aflatoxin B1 to DNA in guinea-pig tissue microsomes. Liu L; Daniels JM; Stewart RK; Massey TE Carcinogenesis; 1990 Nov; 11(11):1915-9. PubMed ID: 2121380 [TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of aflatoxin B1 oxidation by gestodene action on human liver microsomes. Kim BR; Oh HS; Kim DH Biochem Mol Biol Int; 1997 Nov; 43(4):839-46. PubMed ID: 9385444 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of anti-carcinogenesis by indole-3-carbinol. Studies of enzyme induction, electrophile-scavenging, and inhibition of aflatoxin B1 activation. Fong AT; Swanson HI; Dashwood RH; Williams DE; Hendricks JD; Bailey GS Biochem Pharmacol; 1990 Jan; 39(1):19-26. PubMed ID: 2105094 [TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand. Kirby GM; Wolf CR; Neal GE; Judah DJ; Henderson CJ; Srivatanakul P; Wild CP Carcinogenesis; 1993 Dec; 14(12):2613-20. PubMed ID: 8269634 [TBL] [Abstract][Full Text] [Related]
18. Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme. Renaud JP; Cullin C; Pompon D; Beaune P; Mansuy D Eur J Biochem; 1990 Dec; 194(3):889-96. PubMed ID: 2269307 [TBL] [Abstract][Full Text] [Related]
19. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation. Ramsdell HS; Eaton DL Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159 [TBL] [Abstract][Full Text] [Related]
20. In vitro cytochrome P450 monooxygenase and prostaglandin H-synthase mediated aflatoxin B1 biotransformation in guinea pig tissues: effects of beta-naphthoflavone treatment. Liu L; Nakatsu K; Massey TE Arch Toxicol; 1993; 67(6):379-85. PubMed ID: 8215906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]